8-K: NextCure Implements 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing

NextCure, Inc. has completed a one-for-twelve reverse stock split of its common stock, effective July 14, 2025, following stockholder and board approval.

Summary

• NextCure, Inc. effected a 1-for-12 reverse stock split of its common stock, par value $0.001, on July 14, 2025.
• The reverse stock split was approved by stockholders on June 20, 2025, with the Board of Directors subsequently determining the specific 1:12 ratio within an approved range of 1:5 to 1:15.
• The amendment to the company's Third Amended and Restated Certificate of Incorporation became effective at 12:01 a.m. Eastern Time on July 14, 2025.
• The reverse stock split affects all shares of common stock outstanding immediately prior to the effective time.
• It will also reduce the number of shares available for issuance under the 2019 Omnibus Plan and 2019 Employee Stock Purchase Plan, and increase the exercise price per share for outstanding stock options.
• No fractional shares will be issued; stockholders entitled to fractional shares will receive a cash payment based on the closing price of the common stock on the last trading day prior to the effective date.
• The common stock is scheduled to begin trading on the Nasdaq Global Select Market on a split-adjusted basis when the market opens on July 14, 2025, under the existing ticker symbol NXTC.
• The number of authorized shares of common stock will remain at 100 million shares.

Sentiment

Score: 3

Explanation: A reverse stock split is generally viewed negatively by the market as it often signals a company's struggle with a low share price and does not fundamentally improve the company's business or financial health. While it helps maintain exchange listing, it doesn't address the root causes of the low valuation.

Positives

• The reverse stock split is a measure taken to meet minimum bid price requirements for continued listing on the Nasdaq Global Select Market, potentially preventing delisting.
• Maintaining Nasdaq listing can preserve liquidity and investor confidence by ensuring the stock remains accessible to a broader range of institutional and retail investors.

Negatives

• A reverse stock split often indicates a significantly low stock price, which can be a negative signal about the company's past performance or market perception.
• The action itself does not fundamentally change the company's underlying business operations, financial health, or intrinsic value.
• Reverse stock splits can sometimes lead to a further decline in stock price post-split if the underlying issues that led to the low price are not addressed.

Risks

• The underlying reasons for the low stock price that necessitated the reverse split may persist, potentially leading to further stock price depreciation.
• The reverse split itself does not guarantee a sustained increase in share price or continued compliance with Nasdaq listing requirements.
• There is a potential for reduced trading liquidity due to fewer outstanding shares post-split.
• Negative investor perception associated with reverse stock splits could deter new investment.

Future Outlook

The common stock is scheduled to begin trading on the Nasdaq Global Select Market on a split-adjusted basis when the market opens on July 14, 2025, under the existing ticker symbol NXTC.

Management Comments

• "The Corporation has caused this Certificate of Amendment to be signed by the authorized officer below on this 10th day of July, 2025." (Signed by Michael Richman, President and Chief Executive Officer)
• "Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized." (Signed by Steven P. Cobourn, Chief Financial Officer)

Industry Context

Reverse stock splits are a common corporate action, particularly for companies whose stock price has fallen significantly, often below exchange minimum bid price requirements (e.g., Nasdaq's $1.00 minimum). They are typically implemented to avoid delisting and to make the stock appear more attractive to institutional investors who may have policies against investing in 'penny stocks.'

Corporate Governance

Stakeholder Impact

• Shareholders: The number of shares held will be reduced by a 1:12 ratio, while the per-share price is expected to increase proportionally. Stockholders who would otherwise be entitled to a fractional share will receive a cash payment.
• Employees: Shares available for issuance under the 2019 Omnibus Plan and 2019 Employee Stock Purchase Plan will be reduced, and the exercise price per share applicable to outstanding stock options will increase, impacting equity compensation.

Next Steps

• Common Stock to begin trading on a split-adjusted basis on the Nasdaq Global Select Market on July 14, 2025.
• The transfer agent will sell the aggregate of all fractional interests and pay pro rata net proceeds to eligible stockholders as soon as practicable after the effective time.

Key Dates

Recommendation

Keywords

NextCure, NXTC, reverse stock split, stock split, Nasdaq, common stock, corporate action, equity, share consolidation, 8-K filing, corporate governance